Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP669782.RA9325han_OSbbceuWrxfOz9du4WBNatAbVFVM4dn_p3w130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP669782.RA9325han_OSbbceuWrxfOz9du4WBNatAbVFVM4dn_p3w130_assertion type Assertion NP669782.RA9325han_OSbbceuWrxfOz9du4WBNatAbVFVM4dn_p3w130_head.
- NP669782.RA9325han_OSbbceuWrxfOz9du4WBNatAbVFVM4dn_p3w130_assertion description "[Patients with neuroblastoma who were homozygous for the risk alleles at 6p22 were more likely to have metastatic (stage 4) disease (P=0.02), amplification of the MYCN oncogene in the tumor cells (P=0.006), and disease relapse (P=0.01).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP669782.RA9325han_OSbbceuWrxfOz9du4WBNatAbVFVM4dn_p3w130_provenance.
- NP669782.RA9325han_OSbbceuWrxfOz9du4WBNatAbVFVM4dn_p3w130_assertion evidence source_evidence_literature NP669782.RA9325han_OSbbceuWrxfOz9du4WBNatAbVFVM4dn_p3w130_provenance.
- NP669782.RA9325han_OSbbceuWrxfOz9du4WBNatAbVFVM4dn_p3w130_assertion SIO_000772 18463370 NP669782.RA9325han_OSbbceuWrxfOz9du4WBNatAbVFVM4dn_p3w130_provenance.
- NP669782.RA9325han_OSbbceuWrxfOz9du4WBNatAbVFVM4dn_p3w130_assertion wasDerivedFrom befree-2016 NP669782.RA9325han_OSbbceuWrxfOz9du4WBNatAbVFVM4dn_p3w130_provenance.
- NP669782.RA9325han_OSbbceuWrxfOz9du4WBNatAbVFVM4dn_p3w130_assertion wasGeneratedBy ECO_0000203 NP669782.RA9325han_OSbbceuWrxfOz9du4WBNatAbVFVM4dn_p3w130_provenance.